-
1
Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anemia in Predialysis Patients
Published 2016-06-01Subjects: “…C.E.R.A.…”
Get full text
Article -
2
Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient
Published 2020-07-01Subjects: Get full text
Article -
3
Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease
Published 2018-01-01Subjects: “…Epoetin beta pegol (C.E.R.A.)…”
Get full text
Article -
4